Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at Wells Fargo Virtual Healthcare Conference Transcript

Sep 09, 2020 / 03:20PM GMT
Release Date Price: €52 (+0.97%)
Operator

Welcome to the Wells Fargo Healthcare Conference. Before we start, please note that Wells Fargo's Securities events are by invitation only. (Operator Instructions) Also, please be advised that today's conference is being recorded.

Thank you.

Daniel Louis Leonard
Wells Fargo Securities, LLC, Research Division - Senior Analyst

Well, hello, everybody. Sorry about the late start. Thanks for joining us for the fireside chat today with Bio-Techne. Joining us from the company are Chuck Kummeth, CEO; Jim Hippel, CFO; and David Clair from Investor Relations.

I'm Dan Leonard, the life science tools, services and diagnostics analyst with Wells Fargo. The format is fireside chat. If you have a question for management, please raise your hand in Zoom or shoot me an e-mail, and we'll try to address it. I'll lead off with the Q&A.

And with that, welcome, team Bio-Techne. Thanks for being here.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Great. Thanks, Dan.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot